Medicenna Therapeutics Corp. (MDNAF)

Medicenna Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 11, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	47	53	96	45	73	215
Market Cap Growth	-34.01%	-44.25%	111.19%	-38.33%	-65.83%	80.82%
Enterprise Value	35	33	80	19	55	189
Last Close Price	0.56	0.68	1.37	0.63	1.28	4.08
PB Ratio	6.34	4.01	24.95	2.08	4.40	7.09
P/TBV Ratio	6.38	4.03	25.23	2.08	4.42	7.10
Debt / Equity Ratio	0.02	0.01	-	-	-	0.00
Net Debt / Equity Ratio	-1.52	-1.29	-3.27	-1.14	-0.99	-1.06
Net Debt / EBITDA Ratio	0.72	1.21	0.91	2.06	0.92	2.33
Net Debt / FCF Ratio	0.92	1.49	1.04	2.65	0.87	2.64
Quick Ratio	3.82	6.21	6.34	4.95	8.33	9.93
Current Ratio	4.01	6.35	6.66	5.23	8.92	10.26
Return on Equity (ROE)	-91.21%	-97.22%	-146.88%	-39.94%	-76.56%	-46.54%
Return on Assets (ROA)	-53.51%	-53.68%	-42.00%	-34.02%	-42.75%	-27.10%
Return on Capital Employed (ROCE)	-160.60%	-85.20%	-114.80%	-55.30%	-107.90%	-45.60%
Earnings Yield	-21.26%	-15.40%	-19.66%	-16.40%	-24.62%	-6.40%
FCF Yield	-	-21.56%	-12.55%	-20.65%	-25.72%	-5.66%
Buyback Yield / Dilution	-11.18%	-10.10%	-7.57%	-19.25%	-9.31%	-55.68%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.